Pharmaceutical Manufacturing Market by Formulation (Capsules, Injectable, Powders), Drug Development Type (In-House, Outsource), Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2024-2030

Pharmaceutical Manufacturing Market by Formulation (Capsules, Injectable, Powders), Drug Development Type (In-House, Outsource), Route of Administration, Drugs, Age Group, Distribution Channel, Therapy Area - Global Forecast 2024-2030

The Pharmaceutical Manufacturing Market size was estimated at USD 620.68 billion in 2023 and expected to reach USD 672.44 billion in 2024, at a CAGR 8.66% to reach USD 1,110.17 billion by 2030.

Pharmaceutical manufacturing comprises research, development, production, marketing, and distribution of drugs and medicinal products for human use. These products target disease prevention, diagnosis, treatment, and management in various healthcare settings. Key end-users include patients with acute or chronic illnesses, healthcare professionals, clinical trial researchers, insurance companies, and regulatory agencies. Rising aging populations with a higher prevalence of chronic diseases across the globe and increasing need for advanced medicines targeting unmet medical needs influence the growth in the pharmaceutical sector. In addition, rising government funding supports research and development activities in the healthcare sector, allowing new drug development for pharmaceutical companies. However, stringent regulatory requirements imposed by national authorities and the lengthy clinical trial processes create barriers to entry for new pharmaceutical manufacturers.

Moreover, increasing competition from generics and biosimilars and maintaining a robust supply chain pose significant challenges. Furthermore, the technological advancements in drug development processes and a growing focus on personalized medicine create sustainable opportunities for market growth. Also, embracing digital technologies to optimize R&D processes, enhancing the drug development efficiency

Regional Insights

The Americas hold a significant position in the global pharmaceutical market, attributed to its strong research & development (R&D) capabilities, presence of leading pharmaceutical companies, and favorable government policies. The United States has FDA-approved manufacturing facilities focusing on producing biologics and complex generics. European countries, including Germany, France, Switzerland, and the United Kingdom, have advanced pharmaceutical companies with innovative production technologies. These manufacturers have been investing heavily in innovative drug therapies while complying with stringent regulatory standards set by the European Medicines Agency. The Asia Pacific countries initiative aims to boost domestic production and innovation, encouraging investment in R&D and advanced manufacturing technologies. Their policies have led to a surge in new patents filed by pharmaceutical companies. Moreover, the rising investments in healthcare by the private and public sectors in the APAC region fueled the pharmaceutical manufacturing industry.

Market Insights

• Market Dynamics
  
  The market dynamics represent an ever-changing landscape of the Pharmaceutical Manufacturing Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increase in global demand for vaccines and drugs
    • Growing pharmaceutical R&D spending
    • Growth in geriatric population and incidence rate of chronic disorders
    • Market Restraints
      • High costs and complexities associated with the pharma production
      • Market Opportunities
        • Rise in the investment and funding programs in the pharmaceutical manufacturing sector
        • Emergence of novel pharmaceutical manufacturing technologies
        • Market Challenges
          • Stringent government regulations for pharmaceutical companies
          • Market Segmentation Analysis
            • Formulation: Surging investment to support robust research and development of injectable formulations
            • Drug Development Type: Increasing use of outsourced pharmaceutical manufacturing due to its cost effectiveness
            • Route of Administration: Rising research and development activities parenteral drug delivery with rising prevalence of chronic disease
            • Drugs: Inclination toward Over-the-counter (OTC) drugs
            • Age Group: Significant need for drug formulations to treat geriatric medical conditions
            • Distribution Channel: Penetration of non-retail distribution channels for pharmaceuticals
            • Therapy Area: Wave of innovations toward development of new oncology treatment modalities
            • Market Disruption Analysis
            • Porter’s Five Forces Analysis
            • Value Chain & Critical Path Analysis
            • Pricing Analysis
            • Technology Analysis
            • Patent Analysis
            • Trade Analysis
            • Regulatory Framework Analysis
            FPNV Positioning Matrix
            
            The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Pharmaceutical Manufacturing Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
            
            Market Share Analysis
            
            The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Pharmaceutical Manufacturing Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
            
            Recent Developments
            • INR 15,000 Crore Proposed in Pharma Sector, India
              
              The Government of Gujarat, India proposed a significant investment of INR 15,000 crore in pharmaceutical manufacturing. This investment is expected to be made over five years. It aims to establish state-of-the-art infrastructure, attracting major pharmaceutical companies to establish their manufacturing units in the state. This strategic move is projected to generate 1 lakh job opportunities in various fields, including research and development, industrial engineering, production, and logistics.
              
              Glenmark Pharma Launches Triple-Drug FDC of Teneligliptin + Dapagliflozin + Metformin in India for Type 2 Diabetes
              
              Glenmark Pharmaceuticals Limited, a research-led pharmaceutical company, has introduced Zita DM in India. This innovative formulation incorporates teneligliptin (20mg), dapagliflozin (10mg), and metformin SR (500mg/1000mg). Zita DM is prescribed for patients with type 2 diabetes to enhance glycemic control.
              
              Novo, Torrent may Widen Tie-Up
              
              Novo Nordisk India Pvt. Ltd, a pharmaceutical manufacturing company, is considering expanding its partnership opportunities with Torrent Pharmaceuticals Ltd to strengthen its presence in the industry. This decision aims to enhance the company's footprint and solidify its position in the Indian market.
            Strategy Analysis & Recommendation
            
            The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Pharmaceutical Manufacturing Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
            
            Key Company Profiles
            
            The report delves into recent significant developments in the Pharmaceutical Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Actiza Pharmaceutical Pvt. Ltd., Advent Pharma Ltd., Aenova Group GmbH, Amgen Inc., AstraZeneca PLC, Asymchem, Inc., Azurity Pharmaceuticals, Inc., Bayer AG, Biocon Limited, BioNTech SE, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Cipla Limited, Eli Lilly and Company, Emcure Pharmaceuticals Limited, F. Hoffmann-La Roche Ltd., Famar Group, Gilead Sciences, Inc., GlaxoSmithKline PLC, Glenmark Pharmaceuticals Ltd., Johnson & Johnson Services, Inc., Lonza Group AG, Lupin Limited, McKesson Corporation, Merck KGaA, Moderna, Inc., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Piramal Pharma Limited, Recipharm AB, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc., Veranova, L.P., and Zeon Lifesciences Ltd..
            
            Market Segmentation & Coverage
            
            This research report categorizes the Pharmaceutical Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:
            • Formulation
              • Capsules
              • Injectable
              • Powders
              • Sprays
              • Suspensions
              • Tablets
              • Drug Development Type
                • In-House
                • Outsource
                • Route of Administration
                  • Inhalations
                  • Oral
                  • Parenteral
                  • Topical
                  • Drugs
                    • Over-the-Counter (OTC) Medicines
                    • Prescription Medicines
                    • Age Group
                      • Adults
                      • Children & Adolescents
                      • Geriatric
                      • Distribution Channel
                        • Non-Retail
                        • Retail
                        • Therapy Area
                          • Allergy
                          • Cardiovascular Diseases
                          • Dermatology
                          • Diabetes
                          • Gastroenterology
                          • Infectious Disease
                          • Neurology
                          • Oncology
                          • Ophthalmology
                          • Pain Management
                          • Psychiatry
                          • Pulmonary
                          • Renal Disease
                          • Respiratory Diseases
                          • Region
                            • Americas
                              • Argentina
                              • Brazil
                              • Canada
                              • Mexico
                              • United States
                                • California
                                • Florida
                                • Illinois
                                • New York
                                • Ohio
                                • Pennsylvania
                                • Texas
                                • Asia-Pacific
                                  • Australia
                                  • China
                                  • India
                                  • Indonesia
                                  • Japan
                                  • Malaysia
                                  • Philippines
                                  • Singapore
                                  • South Korea
                                  • Taiwan
                                  • Thailand
                                  • Vietnam
                                  • Europe, Middle East & Africa
                                    • Denmark
                                    • Egypt
                                    • Finland
                                    • France
                                    • Germany
                                    • Israel
                                    • Italy
                                    • Netherlands
                                    • Nigeria
                                    • Norway
                                    • Poland
                                    • Qatar
                                    • Russia
                                    • Saudi Arabia
                                    • South Africa
                                    • Spain
                                    • Sweden
                                    • Switzerland
                                    • Turkey
                                    • United Arab Emirates
                                    • United Kingdom
                                    
                                    
                                    Please Note: PDF & Excel + Online Access - 1 Year